Fourthly, the effects of CRMP2 KD in transient SW620 transfectants and the short-term (72 h) of glucose treatment on CRC cells were investigated, which cannot faithfully reflect long-term influences of low CRMP2 expression and hyperglycemia to CRC cells. The gene discussed is DPYSL2; the disease is colorectal carcinoma.